Application of Quercetin in the Treatment of Gastrointestinal Cancers

Seyed Mohammad Ali Mirazimi1, Fatemeh Dashti1, Mohammad Tobeiha1,2

  • 1School of Medicine, Kashan University of Medical Sciences, Kashan, Iran.

Insights

Quercetin, a natural compound found in food, shows promise in fighting gastrointestinal cancers. It inhibits tumor progression through mechanisms like apoptosis and antioxidant effects.

Area of Science:

  • Oncology
  • Natural Products Chemistry
  • Molecular Biology

Background:

  • Cellular signaling pathways regulate critical cell functions like proliferation and apoptosis.
  • Dysregulation of these pathways is implicated in cancer initiation and progression.
  • Natural products are increasingly explored for their therapeutic potential in cancer treatment.

Purpose of the Study:

  • To summarize the therapeutic effects of quercetin in gastrointestinal cancers.
  • To highlight quercetin's mechanisms of action against tumor progression.
  • To review quercetin's role in pancreatic, gastric, colorectal, esophageal, hepatocellular, and oral cancers.

Main Methods:

  • Literature review of studies on quercetin and gastrointestinal cancers.
  • Analysis of quercetin's mechanisms, including cell cycle arrest and apoptosis induction.
  • Examination of quercetin's antioxidant properties in cancer models.

Main Results:

  • Quercetin demonstrates significant inhibitory effects on tumor progression in various gastrointestinal cancers.
  • Key mechanisms include the induction of cell cycle arrest and apoptosis.
  • Antioxidant properties of quercetin contribute to its anti-cancer effects.

Conclusions:

  • Quercetin is a promising natural compound for the treatment of gastrointestinal cancers.
  • Its multifaceted mechanisms of action warrant further investigation for clinical application.
  • Dietary intake of quercetin-rich foods may offer protective benefits against these cancers.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
275
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
341
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K